| Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France (NCT02566148) | ANRS, Emerging Infectious Diseases | 2012-02-01 |
| On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men (NCT01473472) | ANRS, Emerging Infectious Diseases | 2012-01-01 |
| Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV (NCT01407237) | Massachusetts General Hospital | 2012-01-01 |
| Early Antiviral Therapy for Critically Ill HIV Infected Patients (NCT01455688) | Hospital Nossa Senhora da Conceicao | 2012-01-01 |
| RAltegravir Switch STudy: Effects on Endothelial Recovery (NCT01453933) | UMC Utrecht | 2012-01-01 |
| Evaluation of Barriers to Postpartum Care in HIV Infected Women (NCT01853917) | The University of Texas Health Science Center, Houston | 2012-01-01 |
| Atazanavir/Ritonavir and Zinc Pharmacokinetic Study (NCT01475227) | St Stephens Aids Trust | 2011-12-01 |
| Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents (NCT01492803) | University of North Carolina, Chapel Hill | 2011-12-01 |
| Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults (NCT02123433) | University of Siena | 2011-12-01 |
| Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant (NCT01473810) | Oslo University Hospital | 2011-11-01 |
| Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention (NCT01752504) | University of North Carolina, Chapel Hill | 2011-11-01 |
| Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women (NCT01125371) | Johns Hopkins University | 2011-10-01 |
| REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment (NCT01380080) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-10-01 |
| Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression (NCT01471821) | Juan A. Arnaiz | 2011-10-01 |
| The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK) (NCT01271894) | Kirby Institute | 2011-09-01 |
| Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors (NCT01474954) | University of California, San Francisco | 2011-09-01 |
| The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1 (NCT01451333) | Kirby Institute | 2011-09-01 |
| Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy (NCT01307488) | Fundacion SEIMC-GESIDA | 2011-09-01 |
| A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002) (NCT01441193) | Barbara Ensoli, MD | 2011-09-01 |
| Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV (NCT01492842) | University of North Carolina, Chapel Hill | 2011-09-01 |
| A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART (NCT01571466) | Hospital Clinic of Barcelona | 2011-09-01 |
| Enhancement of Connect to Protect® (C2P) (NCT01492816) | University of North Carolina, Chapel Hill | 2011-08-01 |
| A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV (NCT01362634) | Nova Southeastern University | 2011-08-01 |
| Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (NCT01417949) | Universitätsklinikum Hamburg-Eppendorf | 2011-08-01 |
| Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment (NCT01417988) | Prof JMA Lange | 2011-08-01 |
| Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais With HIV Infection (NCT01397669) | SEARCH Research Foundation | 2011-07-01 |
| Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe (NCT01389310) | Bristol-Myers Squibb | 2011-07-01 |
| Switch to Unboosted Atazanavir With Tenofovir Study (NCT01351740) | University of British Columbia | 2011-07-01 |
| Improving Antiretroviral Medication Adherence Among HIV-infected Youth (NCT01347437) | Fenway Community Health | 2011-07-01 |
| An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana (NCT01836003) | Harvard School of Public Health (HSPH) | 2011-07-01 |
| Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM) (NCT01300689) | Chinese Academy of Medical Sciences | 2011-07-01 |
| The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. (NCT01426243) | French National Agency for Research on AIDS and Viral Hepatitis | 2011-07-01 |
| Residual Risk Assessment Of HIV Transmission (NCT01413152) | French National Agency for Research on AIDS and Viral Hepatitis | 2011-07-01 |
| Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients (NCT01679067) | Clara Lehmann | 2011-06-01 |
| Metabolic Abnormalities in HIV-infected Persons (NCT01612858) | Tufts Medical Center | 2011-06-01 |
| Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA) (NCT01367210) | Catholic University of the Sacred Heart | 2011-06-01 |
| Isentress Re-examination Study (MK-0518-115) (NCT01042808) | Merck Sharp & Dohme LLC | 2011-05-01 |
| Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study (NCT01348282) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2011-05-01 |
| Positive Change Agents Program-Tanzania (Evaluation) (NCT01693458) | Harvard School of Public Health (HSPH) | 2011-04-01 |
| The VMVN Study: Virological Monitoring in Viet Nam (NCT01317498) | Beth Israel Deaconess Medical Center | 2011-04-01 |
| Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen (NCT01332955) | ANRS, Emerging Infectious Diseases | 2011-04-01 |
| The Pharmacology/Aging Clinic (NCT01286623) | St Stephens Aids Trust | 2011-04-01 |
| HIV Liver Regeneration Project for HIV Patients With Cirrhosis by Autologous Bone Marrow Transplantation (NCT01309594) | National Center for Global Health and Medicine, Japan | 2011-03-01 |
| Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy (NCT01295515) | National Cancer Institute (NCI) | 2011-02-11 |
| Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study (NCT01207986) | ANRS, Emerging Infectious Diseases | 2011-02-01 |
| Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects (NCT01289106) | Chiang Mai University | 2011-01-01 |
| Impact of Raltegravir on the Viral Reservoirs (NCT01249560) | Centre Hospitalier Universitaire de Nice | 2011-01-01 |
| Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA. (NCT01275443) | St Stephens Aids Trust | 2011-01-01 |
| Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds (NCT01285050) | Johns Hopkins University | 2011-01-01 |
| Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose (NCT01300988) | University of Pennsylvania | 2010-12-01 |
| Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination (NCT02323308) | ANRS, Emerging Infectious Diseases | 2010-12-01 |
| Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects. (NCT01237444) | Pedro Cahn | 2010-12-01 |
| Depot Contraception With and Without Lopinavir/Ritonavir (NCT01231451) | St Stephens Aids Trust | 2010-12-01 |
| Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals (NCT01433289) | Baylor College of Medicine | 2010-12-01 |
| Comparison of HIV Testing Algorithms (NCT01716299) | Medecins Sans Frontieres, Netherlands | 2010-12-01 |
| Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals (NCT01262846) | University of Pennsylvania | 2010-11-01 |
| Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects (NCT01252641) | Sangamo Therapeutics | 2010-11-01 |
| Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas (NCT01193842) | National Cancer Institute (NCI) | 2010-10-06 |
| Assessment of Normal Value of Acoustic Radiation Force Impulse (ARFI) Elastography in HIV Patients (NCT01283243) | Yonsei University | 2010-10-01 |
| Pilot Study of Raltegravir Lipodystrophy IISP (NCT01164605) | Southern California Institute for Research and Education | 2010-10-01 |
| Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients (NCT01359800) | Barbara Ensoli, MD | 2010-10-01 |
| Atripla to Raltegravir Switch Study for CNS Toxicity (NCT01195467) | St Stephens Aids Trust | 2010-10-01 |
| Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression (NCT01194856) | The Cleveland Clinic | 2010-10-01 |
| Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis (NCT01020045) | Emory University | 2010-10-01 |
| Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies (NCT01152918) | HIV Prevention Trials Network | 2010-09-01 |
| Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia (NCT01252537) | Lund University | 2010-09-01 |
| Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires (NCT01214876) | Radboud University Medical Center | 2010-08-01 |
| A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures (NCT01185028) | National Institutes of Health Clinical Center (CC) | 2010-08-01 |
| Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase I (NCT01253850) | Fenway Community Health | 2010-08-01 |
| A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System (NCT01184456) | AIDS Healthcare Foundation | 2010-08-01 |
| Role of HIV on Glutathione Synthesis and Oxidative Stress (NCT01355198) | Baylor College of Medicine | 2010-08-01 |
| A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine (NCT01159743) | AbbVie (prior sponsor, Abbott) | 2010-07-01 |
| Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey (NCT01322932) | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | 2010-07-01 |
| Pilot Study of Metabolic Syndromes and HIV Infections in Indian Tibetans (NCT01261221) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2010-07-01 |
| Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) in Ukraine (NCT01159704) | University of Colorado, Denver | 2010-07-01 |
| Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption (NCT01069809) | Argos Therapeutics | 2010-07-01 |
| Auto-immunity and Pulmonary Arterial Hypertension (NCT01208792) | Assistance Publique - Hôpitaux de Paris | 2010-06-15 |
| Early Versus Delayed BCG Vaccination of HIV-exposed Infants (NCT02062580) | University of Cape Town | 2010-06-01 |
| Male Involvement in Antenatal Care and the Prevention Programme of Mother-to-child Transmission of HIV in Uganda (NCT01144234) | Centre For International Health | 2010-06-01 |
| Cohort of Young Adults Infected With HIV Since Birth or During Childhood (NCT01269632) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-06-01 |
| PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers (NCT01108926) | St Stephens Aids Trust | 2010-06-01 |
| DCVax Plus Poly ICLC in Healthy Volunteers (NCT01127464) | Rockefeller University | 2010-05-01 |
| The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance (NCT01187719) | Radboud University Medical Center | 2010-05-01 |
| Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients (NCT01022476) | ANRS, Emerging Infectious Diseases | 2010-05-01 |
| Test of an Intervention to Improve HIV Care (NCT01103856) | Baylor College of Medicine | 2010-05-01 |
| HIV and Fat Accumulation (NCT01088295) | University of California, Los Angeles | 2010-05-01 |
| The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk (NCT01333644) | University of California, San Francisco | 2010-04-01 |
| Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy (NCT02097381) | University of Roma La Sapienza | 2010-04-01 |
| Evaluating a Microfinance Intervention for High Risk Women in Mongolia (NCT01861431) | Columbia University | 2010-04-01 |
| Safe Drinking Water For Households With Infants Born to HIV-Positive Mothers Pilot Study (NCT01116908) | London School of Hygiene and Tropical Medicine | 2010-04-01 |
| Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults (NCT01155037) | Oswaldo Cruz Foundation | 2010-03-01 |
| Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? (NCT00860977) | University Health Network, Toronto | 2010-03-01 |
| Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation (NCT01138241) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-03-01 |
| Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons (NCT01026454) | University of Washington | 2010-02-01 |
| Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus (NCT02766049) | University of Sao Paulo General Hospital | 2010-02-01 |
| Clinic-based ART Diagnostic Evaluation (NCT01791556) | Walter Reed Army Institute of Research (WRAIR) | 2010-01-26 |
| Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma (NCT01016730) | National Cancer Institute (NCI) | 2010-01-22 |
| Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial (NCT00936195) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-01-01 |
| Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection (NCT01869010) | Hospital Italiano de Buenos Aires | 2010-01-01 |
| Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor (NCT01166477) | Sociedad Andaluza de Enfermedades Infecciosas | 2010-01-01 |